Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Avalon Globocare (NQ: AVCO )

1.130 -0.050 (-4.24%)
Official Closing Price Updated: 7:45 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Avalon Globocare

< Previous 1 2 3 Next >
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular Therapeutics
From GlobeNewswire News Releases
AllPennyStocks.com News: The COVID-19 Pandemic Continues to Fuel Corporate Ingenuity
From SBWire - Latest Press Releases
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
Assure/Fastep® COVID-19 Point-of-Care Antibody Test is the First Test Granted FDA Emergency Use Authorization for Use with Fingerstick Blood Samples 
From GlobeNewswire News Releases
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
From ACCESSWIRE
Avalon GloboCare Provides Clinical Updates on Its CAR-T Immuno-Oncology and Allogeneic Mesenchymal Stromal Cell (MSC) Therapy Programs Following Successful Completion of Phase I AVA-001 Clinical Trial
From GlobeNewswire News Releases
AIM ImmunoTech CEO to Participate in Virtual Panel: 'New Approaches to COVID-19: Hidden Breakthroughs,' on Thursday, September 10th
From ACCESSWIRE
Avalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, September 10th
From GlobeNewswire News Releases
Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Disease (aGVHD)
From GlobeNewswire News Releases
Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit
In anticipation of high demand, Avalon is working with Cellex to source manufacturing facilities and develop next generation COVID-19 testing kits 
From GlobeNewswire News Releases
NetworkNewsBreaks – Avalon GloboCare Corp. (NASDAQ: AVCO) Files Patents, Expands Program Designed to Address Cytokine Storms
From InvestorBrandNetwork
Avalon GloboCare Expands AVA-Trap™ Program to Treat COVID-19 and CAR-T Related Cytokine Storms
From GlobeNewswire News Releases
Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19
From GlobeNewswire News Releases
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
From GlobeNewswire News Releases
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
From GlobeNewswire News Releases
Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board
From GlobeNewswire News Releases
Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ Technology
From GlobeNewswire News Releases
Avalon GloboCare Announces Diagnostic Platform for Point-of-Care Rapid Detection of COVID-19 (SARS-CoV-2) and Its Clinically Relevant Mutation Strains
From GlobeNewswire News Releases
Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers
From GlobeNewswire News Releases
Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization
From GlobeNewswire News Releases
Avalon GloboCare Achieves Major Milestones Advancing Immunotherapeutic Program towards Combatting Cytokine Storm Associated with COVID-19 Lung Damage and Mortality
From GlobeNewswire News Releases
Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020
From GlobeNewswire News Releases
Avalon GloboCare Reaches 'Major Clinical Milestone' by Dosing Its First Patients
From ReleaseWire - Latest Press Releases
Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the “Cellular Therapy in the Asia Pacific Region” Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASTCT and
From GlobeNewswire News Releases
Avalon GloboCare (NASDAQ:AVCO) Announces Initiation of First-in-Human Clinical Trial of Its CAR-T Candidate, AVA-001, for Treatment of B-Cell Malignancies
From ReleaseWire - Latest Press Releases
Avalon GloboCare (NASDAQ:AVCO) Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines
From ReleaseWire - Latest Press Releases
Avalon GloboCare Corp (NASDAQ:AVCO) Is Poised for Market Conquest
From ReleaseWire - Latest Press Releases
Insiders Are Buying Avalon GloboCare Corp. (NASDAQ:AVCO)
From ReleaseWire - Latest Press Releases
Avalon GloboCare to Present at Biotech Showcase™ 2020
From GlobeNewswire News Releases
Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines
From GlobeNewswire News Releases
Avalon GloboCare (NASDAQ:AVCO) to Present at the 12th Annual LD Micro Main Event on December 10th
From ReleaseWire - Latest Press Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.